Study : LEVOBUPIVACAINE Versus Placebo

• Status: Completed
• Trial end date: 2009-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

The locoregional anaesthesia is increasingly important in surgical practice, often allowing to simplify per- and post-operative analgesia. caesarian occurs in 20 % of delivery leading to a longer hospitalization because of the pain resulting from the surgery. The Levobupivacaïne (Chirocaïne) administered through catheters placed in the caesarean scars, showed its efficiency in post-operative analgesia.

Method : realization of a double blind prospective randomized study, control versus placebo Purpose : to show that the local administration of a unique dose of analgesia reduce the post-operative pain with a little or non-invasive technique

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre Hospitalier Universitaire de Saint Etienne
• Treatments: Analgesics; Bupivacaine; Levobupivacaine

Criteria

Inclusion Criteria:

• age > 18 years

• all patients requiring a non-urgent caesarian done according to the Misgav-Ladach technique

Exclusion Criteria:

• Patients requiring very urgent caesarian

• allergic to levobupivacaïne

• with previous history of alcoholism or drug addiction

• with severe hypotension or an ischemic cardiopathy badly compensated or thyrotoxicoses

• treated with first generation of IMAO (monoamine oxidase inhibitor) or with anti-arrhytmia drugs with anesthesic activity